TOI HC I, LLC
SEC CIK 1892154 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STLN | Starling Oncology, Inc. | 10% | 68.0K | — | $3.48M | 8 | 2022-08-12 | 2024-01-19 |
Most active insiders at STLN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chernett Jorey | 10% | $2.69M | — |
| 2 | Hively Brad | Dir | — | $2.00M |
| 3 | Kaushal Mohit | Dir | — | $335.1K |
| 4 | Podnos Yale | Chief Medical Off | — | $276.4K |
| 5 | Pacala Mark L | Dir | — | $200.0K |
| 6 | Carter Robert Ross | CFO | — | $879.32 |
| 7 | England Kristin | Chief Administrative Off | — | — |
| 8 | Langsam Jeffrey | Chief Clinical Off | — | — |
| 9 | Ling Gabriel | Dir | — | — |
| 10 | TOI M, LLC | Dir | — | — |
TOI HC I, LLC made no open-market trades at STLN in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-01-23 | 2024-01-19+ | STLN | Starling Oncology, Inc. | TOI HC I, LLC | 10% | S - Sale | $2.12 | -27.6K | 68.0K | -29% | -$58.6K |
| MI | 2022-10-12 | 2022-10-10+ | STLN | Starling Oncology, Inc. | TOI HC I, LLC | 10% | S - Sale | $4.55 | -60.8K | 14.47M | -0.4% | -$277.0K |
| MI | 2022-10-07 | 2022-10-05+ | STLN | Starling Oncology, Inc. | TOI HC I, LLC | 10% | S - Sale | $4.57 | -62.2K | 14.58M | -0.4% | -$284.2K |
| MI | 2022-09-14 | 2022-09-12+ | STLN | Starling Oncology, Inc. | TOI HC I, LLC | 10% | S - Sale | $5.27 | -128.3K | 15.04M | -0.8% | -$675.5K |
| MI | 2022-09-09 | 2022-09-07+ | STLN | Starling Oncology, Inc. | TOI HC I, LLC | 10% | S - Sale | $5.99 | -87.4K | 15.13M | -0.6% | -$523.4K |
| MI | 2022-09-06 | 2022-09-01+ | STLN | Starling Oncology, Inc. | TOI HC I, LLC | 10% | S - Sale | $5.99 | -157.5K | 15.34M | -1% | -$943.6K |
| MI | 2022-08-26 | 2022-08-24+ | STLN | Starling Oncology, Inc. | TOI HC I, LLC | 10% | S - Sale | $6.15 | -64.6K | 15.49M | -0.4% | -$397.4K |
| MI | 2022-08-16 | 2022-08-12+ | STLN | Starling Oncology, Inc. | TOI HC I, LLC | 10% | S - Sale | $6.49 | -50.0K | 15.61M | -0.3% | -$324.4K |
Purchase Sale Sale after option exercise All abbreviations